These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 115017)

  • 21. Validation of automated behavioral test systems.
    Henck JW; Frahm DT; Anderson JA
    Neurotoxicol Teratol; 1996; 18(2):189-97. PubMed ID: 8709931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The prenatal influence of chloridin and vitamin A on the behavior of the progeny of rats].
    Malakhovskiĭ VG
    Biull Eksp Biol Med; 1971 Mar; 71(3):34-6. PubMed ID: 5105609
    [No Abstract]   [Full Text] [Related]  

  • 23. Behavioral effects of anticholinergic psychotomimetics and their antagonists in man and animals. Panel discussion.
    Gershon S
    Recent Adv Biol Psychiatry; 1965; 8():141-9. PubMed ID: 5332797
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening hallucinogenic drugs: systematic study of three behavioral tests.
    Silva MT; Calil HM
    Psychopharmacologia; 1975 May; 42(2):163-71. PubMed ID: 1080571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral changes and aggressivity evoked by drugs in mice.
    Krsiak M
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):237-57. PubMed ID: 4150439
    [No Abstract]   [Full Text] [Related]  

  • 26. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
    Clemens KJ; McGregor IS; Hunt GE; Cornish JL
    Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic central nervous system toxicity of alcohol.
    Freund G
    Annu Rev Pharmacol; 1973; 13():217-27. PubMed ID: 4576890
    [No Abstract]   [Full Text] [Related]  

  • 28. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS; Drust EG; Damiano BP; Connor JD
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and pharmacological properties of some N-aroylhomotryptamines.
    Misztal S; Boksa J; Chojnacka-Wójcik E; Tatarczyńska E
    Pol J Pharmacol Pharm; 1979; 31(2):149-56. PubMed ID: 315061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The nooglutil correction of functional disorders of the central nervous system caused by prenatal alcoholization in rats].
    Trofimov SS; Ostrovskaia RU; Smol'nikova NM; Khromova IV; Krapivin SV; Krylova AM; Kovalev GI; Gaĭnetdinov RR; Liubimov BI; Voronina TA
    Eksp Klin Farmakol; 1992; 55(1):18-21. PubMed ID: 1305426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of the 2'-chloro substitution on central activity of desmethyldiazepam.
    Babbini M; Gaiardi M; Bartoletti M
    Pharmacology; 1978; 17(3):121-7. PubMed ID: 360230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
    Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening hallucinogenic drugs II. Systematic study of two behavioral tests.
    Calil HM
    Psychopharmacology (Berl); 1978 Jan; 56(1):87-92. PubMed ID: 415331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [PHARMOLOGICAL STUDIES ON HALLUCINOGENS. 2. STUDIES ON THE EFFECT OF LSD25 ON THE CENTRAL NERVOUS SYSTEM].
    MATSUOKA M
    Nihon Yakurigaku Zasshi; 1964 Jan; 60():104-23. PubMed ID: 14156919
    [No Abstract]   [Full Text] [Related]  

  • 35. FACTORS ALTERING BRAIN FUNCTION AND BEHAVIOR IN SCHIZOPHRENIA.
    HEATH RG
    Psychiatr Res Rep Am Psychiatr Assoc; 1964 Dec; 19():178-98. PubMed ID: 14232653
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacological studies of hallucinogens. Report 3. II. Pharmacological studies of influence of psilocybin on the central nervous system].
    Horibe M
    Nihon Yakurigaku Zasshi; 1968 Mar; 64(2):159-85. PubMed ID: 4972692
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacological studies of oxazolazepam, a new psychotropic agent. I. Actions on the central nervous system, especially on the behavioral aspect].
    Takagi H; Kamioka T; Kobayashi S; Suzuki Y; Tachikawa R
    Nihon Yakurigaku Zasshi; 1970; 66(1):107-33. PubMed ID: 4987943
    [No Abstract]   [Full Text] [Related]  

  • 38. Behavioural changes in offspring of rats exposed to diazepam during gestation.
    De Salvia MA; Cagiano R; Cortese I; Renna G; Tattoli M; Tortella E; Cuomo V
    Pharmacol Res; 1989; 21 Suppl 1():27-8. PubMed ID: 2633177
    [No Abstract]   [Full Text] [Related]  

  • 39. Alpha-methyltryptamine revisited via easy Internet access.
    Long H; Nelson LS; Hoffman RS
    Vet Hum Toxicol; 2003 Jun; 45(3):149. PubMed ID: 12776793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hallucinogens in Drug Discrimination.
    Baker LE
    Curr Top Behav Neurosci; 2018; 36():201-219. PubMed ID: 28484970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.